Status:
UNKNOWN
Vitamin D Metabolism in Chronic Kidney Disease Patients
Lead Sponsor:
Memphis VA Medical Center
Conditions:
Vitamin D Metabolism is in Chronic Kidney Disease
Eligibility:
MALE
18-85 years
Phase:
NA
Brief Summary
To determine whether or not chronic kidney disease (CKD), stages III-V and ESRD , is associated with altered vitamin D metabolism related to fibroblast growth factor-23 (FGF-23) stimulation of Cyp24 a...
Detailed Description
1. Patients in the Memphis VA Medical Center with documented vitamin D deficiency, determined by measurements of 25(OH)D3, were recruited for this study. 25(OH)D3 measurements are commonly obtained du...
Eligibility Criteria
Inclusion
- age 18-85 years; CKD stage III or V; serum 25(OH)D level ≤ 30ng/ml, and serum PTH levels \> 70 pg/ml within the last 6 months, informed Consent.
Exclusion
- A history of liver disease, sarcoidosis, intestinal malabsorption;
- requirement of dialysis during the study; serum calcium level \>10.5 mg/dl,
- calcium-phosphorus product \> 70, or
- calcimimetics, or
- phosphorus binders; or
- medications that could affect vitamin D metabolism or
- history of parathyroidectomy.
Key Trial Info
Start Date :
November 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2012
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT01528176
Start Date
November 1 2010
End Date
December 1 2012
Last Update
February 14 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Memphis Veteran Affair Medical center
Memphis, Tennessee, United States, 38194